We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+13.07%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$624M
AUM Growth
+$28.8M
Cap. Flow
-$28M
Cap. Flow %
-4.49%
Top 10 Hldgs %
62.73%
Holding
38
New
5
Increased
9
Reduced
19
Closed
5

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$36.9M
2
VTRS icon
Viatris
VTRS
+$23.1M
3
TAK icon
Takeda Pharmaceutical
TAK
+$13M
4
BMY icon
Bristol-Myers Squibb
BMY
+$11.5M
5
GILD icon
Gilead Sciences
GILD
+$9.6M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.8M
2
SHPG
Shire pic
SHPG
+$21.9M
3
CELG
Celgene Corp
CELG
+$16.9M
4
ELV icon
Elevance Health
ELV
+$9.98M
5
ABT icon
Abbott
ABT
+$9.94M

Sector Composition

Rank Sector Weight
1 Healthcare 98.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELAN icon
26
Elanco Animal Health
ELAN
$12.6B
$7.02M 1.13%
+218,994
New +$6.74M
THC icon
27
Tenet Healthcare
THC
$16.7B
$6.31M 1.01%
218,684
-49,704
-19% -$1.23M
MCK icon
28
McKesson
MCK
$97.3B
$5.79M 0.93%
49,500
-7,000
-12% -$864K
RARE icon
29
Ultragenyx Pharmaceutical
RARE
$2.81B
$4.57M 0.73%
65,935
+57,935
+724% +$3.31M
AGIO icon
30
Agios Pharmaceuticals
AGIO
$2.38B
$3.85M 0.62%
+57,043
New +$3.32M
RDY icon
31
Dr. Reddy's Laboratories
RDY
$10.4B
$3.57M 0.57%
440,380
-415,715
-49% -$3.16M
SGMO
32
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.28M 0.37%
238,857
+83,897
+54% +$857K
LXRX icon
33
Lexicon Pharmaceuticals
LXRX
$1.03B
$2.09M 0.34%
376,502
-486,100
-56% -$2.95M
ALNY icon
34
Alnylam Pharmaceuticals
ALNY
$36.4B
– –
-59,437
Closed -$4.33M
AGN
35
DELISTED
Allergan plc
AGN
– –
-70,000
Closed -$9.36M
ARRY
36
DELISTED
Array Biopharma Inc
ARRY
– –
-240,522
Closed -$3.43M
CELG
37
DELISTED
Celgene Corp
CELG
– –
-263,000
Closed -$16.9M
SHPG
38
DELISTED
Shire pic
SHPG
– –
-125,656
Closed -$21.9M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2019 Portfolio in Review

As of Q1 2019, Sector Gamma AS held 38 positions worth $624M, up 4.8% from $595M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Sector Gamma AS withdrew a net $28M in Q1 2019, closing 5 positions and reducing 19 holdings. Its most notable exit was Shire pic, an estimated $21.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Viatris worth $22.4M.

  • Sector Gamma AS's largest Q1 2019 buy was Viatris: 790,700 shares worth $22.4M.
  • Sector Gamma AS added most to Biogen in Q1 2019, an estimated $36.9M increase.
  • Sector Gamma AS's biggest Q1 2019 reduction was Merck, cutting an estimated $26.8M.
  • Sector Gamma AS fully exited Shire pic in Q1 2019, selling an estimated $21.9M.
  • Sector Gamma AS's ten largest holdings make up 63% of its $624M portfolio in Q1 2019.
  • Sector Gamma AS opened 5 new positions and closed 5 in Q1 2019.
  • Sector Gamma AS's portfolio value rose 4.8% quarter-over-quarter to $624M.

Based on Sector Gamma AS's 13F filing for Q1 2019, filed 13 May 2019.